J&J’s One-Shot Vaccine Is One More Tool in the Toolkit To Fight the Pandemic
The vaccine has advantages over the Pfizer and the Moderna vaccines even though the efficacy rate reported is lower
On Thursday, Johnson & Johnson (J&J) submitted an application seeking emergency use authorization for its single-dose COVID-19 vaccine…